Welcome to our dedicated page for Solesence SEC filings (Ticker: SLSN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Solesence's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Solesence's regulatory disclosures and financial reporting.
Solésence, Inc. filed a Form 8‑K to furnish information under Item 2.02 (Results of Operations and Financial Condition). The company reported that it issued a press release, which is attached as Exhibit 99.1 and incorporated by reference.
The filing also includes a “Solésence Third Quarter 2025 Conference Call Script” as Exhibit 99.2. These materials provide the company’s communications around its quarterly results, with the exhibits serving as the official source documents.
Solésence, Inc. reported Q3 2025 results with total revenue of $14,597, down from $16,866 a year ago, and a net loss of $1,120 versus prior-year income of $3,045. Gross profit was $3,370 compared with $6,102 as cost of revenue rose to $11,227. Selling, general and administrative expense increased to $3,069, reflecting higher legal, credit loss allowance, employee and NASDAQ uplisting costs.
For the nine months, revenue reached $49,581, up from $39,780, and net income was $1,627 versus $4,793. Cash was $429 at quarter end, with operating cash outflow of $10,386 and financing inflows of $11,099, including related-party credit facilities. Accounts receivable, net, increased to $9,709 and the allowance for credit losses to $1,729. Three customers represented 60% of Q3 revenue.
Other items included recognition of $1,234 from the Employee Retention Credit and $194 of related interest. A confidential settlement provides for a $675 payment to Solésence by January 15, 2026. The company also notes BASF supply agreement contingencies that could impact equipment and revenue if triggered.
Solésence, Inc. entered a settlement agreement with Solarium Brands, LLC and A-Frame Brands, LLC to resolve disputes related to previously sold consumer care products. Under the agreement, Solarium will make a one-time settlement payment of $675,000 to Solésence on or before January 15, 2026.
The agreement finalizes a commercial dispute and provides for a defined payment to Solésence. The full agreement was filed with certain confidential portions redacted.
Solesence, Inc. reported an initial Form 3 disclosing that Laura C. Riffner became Chief Financial Officer and received an option to purchase 60,000 shares of common stock on
Solésence, Inc. (SLSN) reported stronger revenue and higher expenses for the quarter and first half of 2025 compared with 2024. Revenue for the three months ended June 30, 2025 was $20,359 thousand versus $13,046 thousand a year earlier, and revenue for the six months was $34,984 thousand versus $22,914 thousand. Total expense for Q2 2025 was $17,692 thousand versus $12,190 thousand in Q2 2024 (six months: $32,237 thousand versus $21,167 thousand). Operating activities used $7,875 thousand in cash in the period while financing activities provided $11,849 thousand. The company amended related-party credit facilities in May 2025 to increase accounts receivable and inventory revolvers and extended maturities to April 30, 2027. Management recognized $1,234 thousand of an Employee Retention Credit and recorded a $572 thousand reserve for the excess payment as a contingent liability included in accrued expenses.